tm logo
PROBIONOV
Dead/Cancelled
IR CANCELLED; US REGISTRATION CANCELLED

on 15 Jun 2022

Last Applicant/ Owned by

F-15130 ARPAJON SUR CERE

FR

Serial Number

79117894 filed on 15th Jun 2012

Registration Number

4296921 registered on 05th Mar 2013

in the Principal Register

Correspondent Address

Bâtiment B

F-69410 CHAMPAGNE AU MONT D'OR

FRANCE

Filing Basis

No Filing Basis

Disclaimer

NO DATA

PROBIONOV

Pharmaceutical preparations used to boost the body's immune system or for treating gynecological diseases, gastroenterological diseases, ear, nose and throat diseases, dermatological diseases; medical preparations, namely, bacteria for use in biological pharmaceutical preparations for treating gynecological, intestinal or gastrenterological diseases, diseases associated with an imbalance in the in Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations used to boost the body's immune system or for treating gynecological diseases, gastroenterological diseases, ear, nose and throat diseases, dermatological diseases; medical preparations, namely, bacteria for use in biological pharmaceutical preparations for treating gynecological, intestinal or gastrenterological diseases, diseases associated with an imbalance in the intestinal or vaginal flora, dermatological, immune, auto-immune and inflammatory or ear, nose and throat diseases; sanitary preparations for medical purposes, namely, bacteria for use in manufacturing biological preparations for treating intestinal or gynecological disorders; biological or chemical preparations for pharmaceutical, medical and sanitary purposes, namely, probiotics, tribiotics, designed to treat gastroenterological, gynecological, ear, nose and throat, dermatological, allergic, immune or inflammatory diseases; preparations for medical purposes, namely, antifungals, antimycotics, anti-flatulence agents, anti-diarrhea agents, antispasmodics, antiinflammatories or antibiotics; preparations to regulate bowel movements for medical use; probiotics in capsule, gel cap or packet form for pharmaceutical purposes for treating or preventing diseases associated with an imbalance in the vaginal or intestinal flora, flatulence, diarrhea, abdominal pain, spasms, for improving regulation of intestinal transit; vaginal capsules for treating gynecological diseases; disinfectants for hygiene care of patients suffering from gastroenterological diseases, imbalance of the intestinal flora, gynecological diseases, imbalance of the vaginal flora; soap-free medical cleansers for gynecological purposes, namely, medical cleanser for skin and body; medicated soap; nutritional supplements, namely, meal replacement foods, beverages, bars adapted for medical use for treating or preventing gynecological, intestinal, gastroenterological diseases, diseases associated with the imbalance of the intestinal flora, vaginal flora, dermatological diseases, immune diseases, auto-immune and inflammatory diseases, ear, nose and throat diseases; vitamin preparations, namely, vitamin supplements; medical preparations for slimming purposes; mineral food supplements; nutritional supplements, namely, meal replacement foods, beverages, bars adapted for medical use made from a combination of probiotics, minerals and/or vitamins

Mark Details


Serial Number

No 79117894

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
08th Jan 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
08th Jan 2023DEATH OF INTERNATIONAL REGISTRATION
31st Jul 2020TOTAL INVALIDATION PROCESSED BY THE IB
01st Jul 2020TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01st Jul 2020INVALIDATION PROCESSED
11th Jun 2020TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
11th Oct 2019CANCELLED SECTION 71
16th Jun 2016CHANGE OF NAME/ADDRESS REC'D FROM IB
06th Sep 2013FINAL DECISION TRANSACTION PROCESSED BY IB
07th Aug 2013FINAL DISPOSITION NOTICE SENT TO IB